HOME  | CONTACT  | PATIENT LOGIN  | CLINIC LOGIN  | FAQ
  • PATIENTS &
    HEALTHY VOLUNTEERS
  • INVESTIGATORS
  • CROS / SPONSORS
  • CAREERS
  • TRIAL ALERTS

TRIALS SEARCH
      
  • HEALTH NEWS

  • RSS FEEDS

  • ABOUT TRIALS

  • LINK TO US


View Clinical Trial (Medical Research Study)


A Pilot Study to Evaluate the Effect of Acupuncture on Epigenetic Regulation of Inflammatory Mediators in Participants With Chronic Low Back Pain

This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials

Signup
Browse Studies

City:   Bethesda
State:   Maryland
Zip Code:   20892
Conditions:   Pain
Purpose:   Background: - Acupuncture is a traditional Chinese medical treatment. Thin needles are used to stimulate specific points in the body. Previous studies have found that acupuncture can be useful in treating low back pain. This study will explore how acupuncture affects low back pain. Researchers will look at blood samples for changes in different chemicals related to inflammation and pain. Objectives: - To test the effect of acupuncture on blood chemicals associated with chronic low back pain. Eligibility: - People at least 18 years of age who have chronic low back pain. - Those who have had back surgery or had acupuncture for any medical condition may not participate. Design: - This study requires eight visits over 2 to 3 weeks. Each visit will take 1.5 to 2 hours. - At the first study visit, participants will give a medical history and complete two questionnaires about their low back pain. They will also spend 30 minutes lying down on a bed, relaxing quietly. - The next visits will occur every 2 to 3 days for the next 2 weeks. Participants will receive 30 minutes of either sham or standard acupuncture. Sham acupuncture will mimic the standard procedure, but no needles will be used. The standard procedure will be performed in the same location. A licensed, experienced acupuncturist will insert small disposable needles into acupuncture sites on the back, arms, and legs. Those in the study will not know whether they are receiving the sham or the standard acupuncture procedure. - At some visits, participants will provide blood samples for testing. At every visit, participants will complete the questionnaires about low back pain.
Study Summary:   Objective: Inflammation and primary mechanical derangements are thought to be the two major causes leading to low back pain (LBP) syndromes. Increasing evidence suggests that cytokines and hormones, including IFN-gamma, IL-17, IL-1beta, IL-6, TNF-alpha, MMP10, NGF, PGE2, NO and IL-8, play critical roles in the pathogenesis of inflammatory LBP. This study will investigate the effect of acupuncture on LBP by measuring serum cytokine and hormone levels before and after treatment in participants. To define the molecular mechanism by which acupuncture affects LBP, histone modification, including H3K4me3 and H3K27me3, as well as methylation patterns of CpG islands on the promoters of selected genes in the peripheral CD4(plus) T cells will be also tested. Study Population: Five participants with chronic LBP will receive treatment. Design: In this non-randomized, single group pilot study, participants will be given sham acupuncture and subsequently treated with acupuncture for a total of eight visits over the span of 17 days. Blood will be drawn and analyzed at scheduled intervals. Outcome Measure: The primary outcome is to investigate the potential effect of acupuncture treatment, as compared to sham acupuncture and quiet relaxation, on the regulation of IFN-gamma and IL-17 in participants with LBP, including the serum level of these two cytokines, frequency of CD4(plus)IFN-gamma(plus) and CD4(plus)IL-17(plus) cells in the peripheral blood, and the patterns of H3K4me3, H3K27me3 and DNA methylation on their promoters in CD4(plus) T cells in response to acupuncture treatment. Secondary outcomes investigate the effects of acupuncture, as compared to sham acupuncture and quiet relaxation, on the following outcome measures: level of serum cytokines and hormones, including IL-1beta, TNF-alpha, MMP10, NGF, PGE2, NO, IL-8, IL-6, TGF-beta, IL-10, IL-22, IL-23 and IL-17F before and after acupuncture treatment; genome-wide gene expression profile of CD4(plus) T cells before and after acupuncture treatment; genome-wide patterns of H3K4me3 and H3K27me3 modification in CD4(plus) T cells before and after acupuncture treatment; genome-wide patterns of H3K4me3 and H3K27me3 modification in CD4(plus)T cells before and after acupuncture treatment; DNA methylation status change of selected CpG islands before and after acupuncture treatment; and the severity of LBP before and after two weeks of acupuncture treatment according to the Brief Pain Inventory-Short Form (BPI-SF) for pain severity, as well as the Randall Morris Disability Questionnaire (RMDQ) for LBP-related interference scores.
Criteria:   - INCLUSION CRITERIA: - Participant must be greater than or equal to 18 years of age. - Participant must understand and sign the protocol's informed consent document. - Participant must have been diagnosed with chronic LBP between 3-12 months prior to enrollment. - Participant must have LBP of greater than or equal to 3 points on a scale of 0 to 10 recorded on the BPI-SF at enrollment. - Participant must have a RMDQ score of greater than or equal to 3. - Participant must be able to comprehend English in order to complete questionnaires. EXCLUSION CRITERIA: - Participant is unable to comply with study procedures or follow-up visits. - Participant is in another investigational study and actively receiving study therapy for LBP. - Participant has received prior treatment with acupuncture for any medical conditions. - Participant used analgesics, such as opiates or tramadol, within 30 days of enrollment. - Participant has a significant medical or psychiatric condition that would preclude study completion as determined by the investigator. - Participant has received corticosteroid treatment within 3 months of enrollment. - Participant is receiving physical therapy, heat therapy, ultrasound, spinal manipulation, cognitive-behavioral therapy, biofeedback or anticonvulsants for his/her LBP. - Participant has had back surgery.
NCT ID:   NCT01376375
Primary Contact:   Principal Investigator
Cailin C Sibley, M.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Backup Contact:   N/A
Location Contact:   Bethesda, Maryland 20892
United States



There is no listed contact information for this specific location.

Site Status: N/A

Data Source:   ClinicalTrials.gov
Date Processed:   May 24, 2013
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


  • NEARBY STUDIES

Within 25 Miles

Crohn's Disease - Chevy Chase MD

Healthy Volunteers (Ages 18-50) - Bethesda MD

Alcohol - Bethesda MD

Irritable Bowel Syndrome with Diarrhea (IBS-D) - Chevy Chase MD

G6PD Deficient Adults (Ages 18 to 62) - Silver Spring MD

Excessive Daytime Sleepiness with Narcolepsy - Chevy Chase MD

Restless Legs Syndrome (RLS) - Chevy Chase MD

Anti-Depressant Induced Sexual Dysfunction - Washington DC

Anti-Depressant Induced Sexual Dysfunction - Gaithersburg MD

Asthma (Ages 18-65) - Wheaton MD

Brain Tumor (Glioblastoma) - Bethesda MD

Crohn’s Disease or Ulcerative Colitis - Bethesda MD

Healthy Volunteers (Ages 18-50) - Silver Spring MD

Within 50 Miles

Type 2 Diabetes - Baltimore MD

Healthy Volunteers (Ages 18-75) - Baltimore MD

Crohn's Disease - Annapolis MD

Smoking - Baltimore MD

Multiple Sclerosis - Baltimore MD

Orthostatic Hypotension - Baltimore MD

Chronic Fatigue Syndrome - Baltimore MD

Irritable Bowel Syndrome with Diarrhea (IBS-D) - Towson MD

Arthritis - Frederick MD

Parkinson's Disease - Baltimore MD

Postherpetic Neuralgia (Post-Shingles Pain) - Towson MD

Irritable Bowel Syndrome (with diarrhea) - Annapolis MD

Excessive Daytime Sleepiness with Narcolepsy - Towson MD

Smoking - Baltimore MD

Osteoarthritis of the Knee - Towson MD

Multiple Sclerosis - Baltimore MD

Asthma (Ages 18-65) - White Marsh MD

Gout - Manassas VA

Anti-Depressant Induced Sexual Dysfunction - Baltimore MD

Alzheimer's Disease - Towson MD

Methamphetamine Use - Baltimore MD

Healthy Volunteers (Ages 18-65) - Baltimore MD

Orthostatic Hypotension (Low Blood Pressure Upon Standing) - Baltimore MD

Alzheimer's Disease - Baltimore MD

Memory Loss - Baltimore MD

Within 100 Miles

Pediatric Depression - Richmond VA

Arthritis - Hagerstown MD

Restless Legs Syndrome (RLS) - Charlottesville VA

Irritable Bowel Syndrome (with diarrhea) - Richmond VA

COPD (Emphysema and Chronic Bronchitis) - Richmond VA1

Chronic Obstructive Pulmonary Disorder (COPD) - Richmond VA

Eczema - Henrico VA

 
Clinical Connections Home | Investigators | CROs / Sponsors | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Links | Terms And Conditions | Sitemap | Suggestions / Feedback
© 1998-2013 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.